Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Observational × Aromatase Inhibitors × Clear all

Status

Sponsor Class

OTHER 7 INDUSTRY 6 UNKNOWN 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hormone Receptor Positive Advanced Breast Cancer 1

Interventions

palbociclib 2 Fulvestrant 2 pembrolizumab 1 niraparib 1 exemestane 1 Therapeutics 1 Standard of Care 1 Radiotherapy, Adjuvant 1 Radiation 1 Pharmaceutical Preparations 1 Neoadjuvant Therapy 1 Methods 1 Letrozole 1 Immunotherapy 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05000736 2022-04-29

CAPACITY

ChineseAMS

Hormone Receptor Positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡